Author

N. S. Alhaggass

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Pangenome-Guided In Silico Design and Structural Evaluation of a Multi-Epitope Vaccine Candidate Against Streptococcus suis

Background/Objectives: Streptococcus suis is an important zoonotic pathogen responsible for severe infections in animals and humans, and the emergence of diverse strains has reduced the effectiveness of conventional antimicrobial therapies. Since there is no broadly protective vaccine, there is a need for new vaccinati...

N. S. Alhaggass, Waad A. Aljohani, Reem Alromaihi et al. · Pharmaceuticals · 0 citations

Open access Aug 2026

Network pharmacology-guided subtractive proteomics coupled with molecular docking and molecular dynamics simulation identifies Nigella sativa as a potential anti-sepsis therapeutic

Sepsis is a life-threatening condition caused by a dysregulated host immune response to infection, often leading to organ failure. Increasing antibiotic resistance, particularly in Streptococcus pneumoniae, highlights the urgent need for alternative therapeutic strategies. Nigella sativa, known for its anti-inflammator...

Kinza Alamgir, Sher Muhammad, Muhammad Shahid et al. · Scientific Reports · 0 citations

Open access Sep 2026

Identification of natural TLR4 modulators through network pharmacology and molecular modeling in SARS-CoV-2 Acinetobacter baumannii co-infection

Viral–bacterial co-infection with SARS-CoV-2 and Acinetobacter baumannii exacerbates hyperinflammation via Toll-like receptor 4 (TLR4)-mediated immune pathways. Using network pharmacology, an integrated protein–protein interaction network identified 30 key inter-species hubs comprising viral, bacterial, and human host...

M. Ouassaf, S. U. Khan, K. R. Rengasamy et al. · Frontiers in Chemistry · 0 citations